Bacillary Dysentery (Shigellosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 40 pages | ID: B88FE3428C33EN
VPAResearch

Abstracts

Bacillary Dysentery (Shigellosis) Drug pipeline report- 2020 is an annual R&D review of Bacillary Dysentery (Shigellosis) pipeline candidates. The report presents the current status of all major Bacillary Dysentery (Shigellosis) therapeutic compounds. Detailed insights into Bacillary Dysentery (Shigellosis) pipeline development, current status, companies, drug profiles and Bacillary Dysentery (Shigellosis) preclinical and clinical trials are included.

2020 Bacillary Dysentery (Shigellosis) Pipeline Market Insights
Bacillary Dysentery (Shigellosis) disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Bacillary Dysentery (Shigellosis) therapies, pipeline by phase and others are included.

Bacillary Dysentery (Shigellosis) pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Bacillary Dysentery (Shigellosis) Therapeutic Drug candidates
Both active and inactive Bacillary Dysentery (Shigellosis) pipeline drug candidates are included in the report

Bacillary Dysentery (Shigellosis) Clinical Trials and preclinical Studies
Bacillary Dysentery (Shigellosis) In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Bacillary Dysentery (Shigellosis) pipeline market developments
Bacillary Dysentery (Shigellosis) Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Bacillary Dysentery (Shigellosis) pipeline companies in active development
The report analyzes Bacillary Dysentery (Shigellosis) pipeline of the below companies-

Akthelia Pharmaceuticals Ltd, EveliQure Biotechnologies GmbH, GlaxoSmithKline Plc, Immuron Ltd, LimmaTech Biologics AG, Protein Potential LLC

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
6 Companies investing in Bacillary Dysentery (Shigellosis) pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Bacillary Dysentery (Shigellosis) pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. BACILLARY DYSENTERY (SHIGELLOSIS) PIPELINE MARKET INSIGHTS, 2020

1.1 Bacillary Dysentery (Shigellosis) Disease Overview
1.2 Bacillary Dysentery (Shigellosis) Drug Pipeline Snapshot, 2020
  1.2.1 Bacillary Dysentery (Shigellosis) Pipeline Drugs by Phase
  1.2.2 Bacillary Dysentery (Shigellosis) Pipeline Drugs by Company
  1.2.3 Bacillary Dysentery (Shigellosis) Pipeline Drugs by Mechanism of Action
  1.2.4 Bacillary Dysentery (Shigellosis) Pipeline Drugs by Route of Administration

2. BACILLARY DYSENTERY (SHIGELLOSIS) COMPANY WISE PIPELINE DETAILS

Akthelia Pharmaceuticals Ltd Bacillary Dysentery (Shigellosis) Pipeline Drugs
  Company Profile
  Drug Candidate Details
EveliQure Biotechnologies GmbH Bacillary Dysentery (Shigellosis) Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Bacillary Dysentery (Shigellosis) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Immuron Ltd Bacillary Dysentery (Shigellosis) Pipeline Drugs
  Company Profile
  Drug Candidate Details
LimmaTech Biologics AG Bacillary Dysentery (Shigellosis) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Protein Potential LLC Bacillary Dysentery (Shigellosis) Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. BACILLARY DYSENTERY (SHIGELLOSIS) DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. BACILLARY DYSENTERY (SHIGELLOSIS) PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts